Teva CEO: The industry is undergoing a shakeup


Erez Vigodman- TEVA

“Size is important in the industry, but it isn’t everything. It’s important to be better. You have to make acquisitions that will suit the company’s strategic direction and contribute to its differentiation, not just in order to be bigger, ” Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) president and CEO Erez Vigodman said at a conference of Sanara Ventures, a joint technology incubator of Teva and Royal Philips Electronics focusing on medical equipment and technologies. Teva is in the midst of an attempt to take over Mylan Pharmaceuticals (MYL), its competitor, in a deal worth over $40 billion.

In a talk with Royal Philips CEO Frans van Houten and Sanara CEO Assaf Barnea, Vigodman was asked about the mergers and acquisitions trend in the industry (there were several recent mega-deals in the medical equipment industry)…


GLOBES logo-eng (1) Published by Globes [online], Israel business news –


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.